SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
SVF Bluebird (Cayman) Ltd

(Last) (First) (Middle)
C/O WALKERS CORP LTD CAYMAN CORP CENTRE
27 HOSPITAL ROAD GEORGE TOWN

(Street)
GRAND CAYMAN E9 KY1-9008

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/05/2019
3. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 27,850,460(1) D(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
SVF Bluebird (Cayman) Ltd

(Last) (First) (Middle)
C/O WALKERS CORP LTD CAYMAN CORP CENTRE
27 HOSPITAL ROAD GEORGE TOWN

(Street)
GRAND CAYMAN E9 KY1-9008

(City) (State) (Zip)
1. Name and Address of Reporting Person*
SVF Enterprise (Cayman) Ltd

(Last) (First) (Middle)
C/O WALKERS CORP LTD CAYMAN CORP CENTRE
27 HOSPITAL ROAD GEORGE TOWN

(Street)
GRAND CAYMAN E9 KY1-9008

(City) (State) (Zip)
1. Name and Address of Reporting Person*
SVF Endurance (Cayman) Ltd

(Last) (First) (Middle)
C/O WALKERS CORP LTD CAYMAN CORP CENTRE
27 HOSPITAL ROAD GEORGE TOWN

(Street)
GRAND CAYMAN E9 KY1-9008

(City) (State) (Zip)
Explanation of Responses:
1. This filing on Form 3 is being filed as a result of a private transfer of 27,850,460 shares of Common Stock of the Issuer by SoftBank Vision Fund (AIV M1) L.P. ("AIV M1") to SVF Bluebird (Cayman) Limited ("SVF Bluebird"). SVF Bluebird is a wholly-owned subsidiary of SVF Enterprise (Cayman) Limited ("SVF Enterprise"). SVF Enterprise is a wholly-owned subsidiary of SVF Endurance (Cayman) Limited ("SVF Endurance"). SVF Endurance is a wholly-owned subsidiary of AIV M1. After the transfer, SVF Bluebird became a direct owner of the 27,850,460 shares of Common Stock of the Issuer and SVF Enterprise, SVF Endurance and AIV M1 became indirect owners of the 27,850,460 share of Common Stock of the Issuer. The transferred shares of the Issuer will remain subject to a Lock-Up Agreement, dated May 20, 2019, by and among AIV M1, J.P. Morgan Securities LLC, and BofA Securities, Inc.
/s/ Karen Ellerbe, Director 07/15/2019
/s/ Karen Ellerbe, Director 07/15/2019
/s/ Karen Ellerbe, Director 07/15/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.